New year, new scene for Sibylla! Happy to announce our relocation to business & biotech hub, Milan, an important life sciences cluster in Europe & home to an array of international biotechs & renowned research institutions. Stay tuned for further growth updates!
#FoldtheFuture
Enjoying the young, creative energy on-site at this year’s StartupItalia Open Summit in Milan! After only three years of launching Sibylla’s operations, it is an honor to be listed as one of the top 10 Italian startups of 2022. #SIOS22#foldthefuture#sibylla#startup#biotech
Most conventional drug design focuses on the native structure of a target protein. At Sibylla, we
apply a completely different strategy: targeting the protein while it folds – an otherwise near-impossible task enabled by our PPI-FIT technology. More at https://t.co/DhlngHz6tg
Countdown to a new star ⏳
Hidden in the neck of this “hourglass” of light are the very beginnings of a new star — a protostar. The clouds of dust and gas within this region are only visible in infrared light, the wavelengths that Webb specializes in: https://t.co/DtazblATMW
This week, meet our Head of Medicinal Chemistry Lab Alexandros Patsilinakos at Discovery On Target 2022 in Boston! He will attend the Artificial Intelligence in Drug Discovery program. #ArtificialIntelligence#DrugDiscovery#sibylla#foldthefuture
What a milestone for us at @SibyllaBiotech .to the entire team & our investors for enabling us to close a successful #SeriesA & one of the biggest in Italian #biotech. Follow us as we work toward transforming the protein degradation space.
https://t.co/Aoslsj3OOf